Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
J Natl Compr Canc Netw ; 22(8)2024 07 30.
Artículo en Inglés | MEDLINE | ID: mdl-39079545

RESUMEN

BACKGROUND: Mohs micrographic surgery (MMS) is a promising treatment modality for melanoma in situ (MIS). However, variations in surgical technique limit the generalizability of existing data and may impede future study of MMS in clinical trials. METHODS: A modified Delphi method was selected to establish consensus on optimal MMS techniques for treating MIS in future clinical trials. The Delphi method was selected due to the limited current data, the wide range of techniques used in the field, and the intention to establish a standardized technique for future clinical trials. A literature review and interviews with experienced MMS surgeons were performed to identify dimensions of the MMS technique for MIS that (1) likely impacted costs or outcomes of the procedure, and (2) showed significant variability between surgeons. A total of 8 dimensions of technical variation were selected. The Delphi process consisted of 2 rounds of voting and commentary, during which 44 expert Mohs surgeons across the United States rated their agreement with specific recommendations using a Likert scale. RESULTS: Five of eight recommendations achieved consensus in Round 1. All 3 of the remaining recommendations achieved consensus in Round 2. Techniques achieving consensus in Round 1 included the use of a starting peripheral margin of ≤5 mm, application of immunohistochemistry, frozen tissue processing, and resecting to the depth of subcutaneous fat. Consensus on the use of Wood's lamp, dermatoscope, and negative tissue controls was established in Round 2. CONCLUSIONS: This study generated 8 consensus recommendations intended to offer guidance for Mohs surgeons treating MIS. The adoption of these recommendations will promote standardization to facilitate comparisons of aggregate data in multicenter clinical trials.


Asunto(s)
Consenso , Técnica Delphi , Melanoma , Cirugía de Mohs , Neoplasias Cutáneas , Humanos , Cirugía de Mohs/normas , Cirugía de Mohs/métodos , Melanoma/cirugía , Melanoma/patología , Neoplasias Cutáneas/cirugía , Neoplasias Cutáneas/patología , Ensayos Clínicos como Asunto/normas
2.
J Am Acad Dermatol ; 90(6): 1226-1231, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38253130

RESUMEN

BACKGROUND: Although current guidelines recommend a 5 mm surgical margin for the excision of melanoma in situ (MIS), increasing evidence has shown this may be suboptimal to achieve tumor clearance. OBJECTIVE: To evaluate margins required for optimal cure rates with excision of MIS on the head and neck and investigate tumor and/or patient factors in those requiring >5 mm margins to achieve tumor clearance. METHODS: A retrospective chart review was performed on 846 (807 primary and 39 recurrent) MIS cases on the head and neck treated in the authors' dermatologic surgery department over a 126-month (10.5 year) period. RESULTS: Sixty-two percent were cleared with 5 mm margins. A total of 15 mm margins were required to achieve a 97% clearance rate. Difference in clearance rate between margin thresholds was significant (P < .001). Tumor location on the cheek and larger preoperative size correlated with requiring >5 mm margins to achieve tumor clearance (P = .006 and P = .001, respectively). LIMITATIONS: This is a single-center retrospective study which relies on accurate documentation of clinical data. CONCLUSION: This study demonstrates that MIS on the head and neck often requires margins >5 mm margins to achieve tumor clearance. When Mohs micrographic surgery is not possible, excision margins of ≥10 mm are likely necessary for head and neck tumors.


Asunto(s)
Neoplasias de Cabeza y Cuello , Márgenes de Escisión , Melanoma , Cirugía de Mohs , Neoplasias Cutáneas , Humanos , Cirugía de Mohs/métodos , Estudios Retrospectivos , Melanoma/cirugía , Melanoma/patología , Neoplasias Cutáneas/cirugía , Neoplasias Cutáneas/patología , Femenino , Masculino , Neoplasias de Cabeza y Cuello/cirugía , Neoplasias de Cabeza y Cuello/patología , Persona de Mediana Edad , Anciano , Adulto , Anciano de 80 o más Años , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/patología , Recurrencia Local de Neoplasia/prevención & control , Resultado del Tratamiento
3.
Dermatol Surg ; 50(3): 241-246, 2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38170669

RESUMEN

BACKGROUND: Currently, there are limited reviews in the dermatology literature on how to approach reconstruction of nasal lining in full-thickness nasal defects resulting from Mohs micrographic surgery. Given variable training and experience, dermatologic surgeons may seek additional references to help reconstruct certain advanced defects. We sought to synthesize literature from dermatologic surgery, plastic surgery, and otolaryngology to review repair options and considerations for repair of nasal lining defects. OBJECTIVE: To present a comprehensive literature review of repair options for nasal lining reconstruction and discuss advantages, disadvantages, specific anatomic considerations, and techniques to execute such options. MATERIALS AND METHODS: Articles from several different reconstructive specialties including dermatologic/Mohs surgery, otolaryngology, and plastic and reconstructive surgery were reviewed. Instructive images were compiled to illustrate several techniques, with additional medical illustration recreations included to help showcase important reconstructive approaches. RESULTS: A comprehensive descriptive review of nasal lining repair options for the reconstructive surgeon. CONCLUSION: Advanced tumors can result in full-thickness nasal defects, and this review describes various reconstructive options for reconstruction based on the extent of the defect.


Asunto(s)
Otolaringología , Procedimientos de Cirugía Plástica , Cirujanos , Humanos , Cirugía de Mohs/efectos adversos , Nariz/cirugía
4.
Dermatol Surg ; 2024 Sep 16.
Artículo en Inglés | MEDLINE | ID: mdl-39282963

RESUMEN

BACKGROUND: Treatment of basal cell carcinoma (BCC) is recommended. However, patients often note that the biopsy site appears resolved and inquire about the need for additional treatment. OBJECTIVE: This study aims to determine the rate of residual BCC on excision specimens after initial shave biopsy to aid in decision-making on the necessity of further treatment. METHODS AND MATERIALS: A retrospective chart review was conducted that reviewed excision specimen pathology reports of previously biopsy-proven basal cell carcinomas for the presence of residual tumor between 2012 and 2022 at a single institution. RESULTS: Two thousand one hundred seventeen cases met inclusion criteria. Overall, 39.4% of patients had residual BCC after an initial shave biopsy. Using an odds ratio and 95% confidence interval, a significant relationship was found between larger lesions, longer time between biopsy and excision, and lesions on high-risk body sites with increased odds of residual BCC. A significant relationship was found between negative or not specified margins on shave biopsy with decreased odds of residual BCC. CONCLUSION: The results show that a large percentage of patients have residual BCC following initial biopsies. These results should be included in physician-patient discussions about treatment options for BCC.

5.
Pediatr Dermatol ; 38(4): 879-882, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34227145

RESUMEN

A 7-year-old girl with a history of Langerhans cell histiocytosis (LCH), in remission, presented with the sudden appearance of multiple, agminated nevi. Skin biopsy revealed a benign junctional nevus, without recurrence of LCH. Subsequent immunohistochemical testing of both the skin and iliac wing biopsies demonstrated a BRAF V600E mutation. MAPK pathway mutations have been implicated in both LCH and nevogenesis.


Asunto(s)
Histiocitosis de Células de Langerhans , Nevo Pigmentado , Nevo , Neoplasias Cutáneas , Niño , Femenino , Histiocitosis de Células de Langerhans/complicaciones , Histiocitosis de Células de Langerhans/diagnóstico , Humanos , Mutación , Recurrencia Local de Neoplasia , Proteínas Proto-Oncogénicas B-raf/genética
6.
Dermatol Surg ; 2024 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-39451016
11.
Pacing Clin Electrophysiol ; 37(8): 978-85, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25060820

RESUMEN

BACKGROUND: The use of cardiac implantable electronic devices (CIEDs) has expanded dramatically over the past decade, but net clinical benefit has been curtailed by increasing infectious complications. In particular, CIED-related infectious endocarditis (IE) is a serious condition with significant morbidity and mortality. METHODS: We performed a single-center, retrospective study between July 2006 and February 2011 with CIED-related IE, defined by either lead vegetations detected on echocardiography or by fulfilling Duke criteria for definite endocarditis. Clinical parameters and outcomes were detailed by electronic medical record review and vital status was confirmed by the Social Security Death Index. RESULTS: Eighty patients (median age 67, interquartile range 56-75, 58 M/22 F) were diagnosed with CIED-related IE. Overall mortality was 36% with a median time to death of 95 days from presentation. Over half (52%) of the deaths were infection related with a median time to death of 29 days. Multivariate analysis showed methicillin-resistant Staphylococcus aureus (MRSA) infection (odds ratio [OR] 0.158; 95% confidence interval [CI], 0.047-0.534; P = .003) and concomitant valve endocarditis (OR 0.141, CI 0.041-0.491, P = .002) independently predicted mortality. CONCLUSION: In this contemporary series, all-cause mortality in patients with CIED-related IE was high with a short time to death from onset of infection. MRSA and concomitant valve infection were the most powerful independent predictors of mortality.


Asunto(s)
Desfibriladores Implantables/efectos adversos , Endocarditis Bacteriana/etiología , Marcapaso Artificial/efectos adversos , Infecciones Relacionadas con Prótesis/etiología , Anciano , Femenino , Humanos , Masculino , Staphylococcus aureus Resistente a Meticilina , Persona de Mediana Edad , Infecciones Relacionadas con Prótesis/diagnóstico , Infecciones Relacionadas con Prótesis/terapia , Estudios Retrospectivos , Resultado del Tratamiento
12.
Arch Dermatol Res ; 315(10): 2989-2990, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-37709967

Asunto(s)
Refugiados , Humanos , Siria
13.
JAMA Dermatol ; 159(6): 661, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-37074704

RESUMEN

This case report describes symmetrically distributed red to violaceous fine telangiectasias in a lacelike pattern on the dorsal feet and ankles.


Asunto(s)
Telangiectasia , Humanos , Telangiectasia/diagnóstico
14.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA